ARC-13950

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameARC-13950
Drug Alias NameFPL-13950
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptors inhibitors
TargetsGlutamate receptors
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca R&D Charnwood
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca R&D Charnwood
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A